Even Healthcare is a managed-care healthtech startup based in Bengaluru, India, that provides membership-based consultations, diagnostics and cashless hospitalisation for individuals and families.

This Startup Deep Dive explains what Even Healthcare does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Even Healthcare in Brief

• What it is: Even Healthcare is an Indian Managed care and hospitals company based in Bengaluru.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Even sells membership plans that bundle doctor consultations, diagnostic tests, personalised care programmes and cashless hospitalisation via partner insurers.
• The annual membership fee is reported at INR 4,800, with an optional hospital-coverage add-on.
• Early hospital partners included Narayana Health, Fortis Hospitals and Aster DM Healthcare.
• Funding: About $70M (reported).

Even Healthcare Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Even Healthcare?

Even Healthcare operates in the Managed care and hospitals space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Even Healthcare.

• Even sells membership plans that bundle doctor consultations, diagnostic tests, personalised care programmes and cashless hospitalisation via partner insurers.
• The annual membership fee is reported at INR 4,800, with an optional hospital-coverage add-on.
• Early hospital partners included Narayana Health, Fortis Hospitals and Aster DM Healthcare.
• It opened its first multi-specialty Even Hospital in Bengaluru in May 2025.

The Origin Story of Even Healthcare

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Mayank Banerjee, Matilde Giglio, Alessandro Ialongo.
• Even was founded in 2020 by Mayank Banerjee, Matilde Giglio and Alessandro Ialongo.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Managed care and hospitals sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2021: Seed round of $5M led by Khosla Ventures (reported).
• November 2022: $15M from Alpha Wave and Aspada (reported).
• October 2024: $30M Series A led by Khosla Ventures (reported).
• May 2025: Launched first hospital; company said it reached operating break-even there within six months (company-stated).

Even Healthcare Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Seed, 2021: $5M led by Khosla Ventures (reported).
• November 2022: $15M from Alpha Wave and Aspada (reported).
• Series A, October 2024: $30M led by Khosla Ventures with Founders Fund, 8VC and Lachy Groom (reported).
• January 2026: $20M led by Lachy Groom and Alpha Wave, with Sharrp Ventures (reported).

How Does Even Healthcare Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Subscription memberships combined with managed care and cashless hospitalisation through insurer and hospital partnerships, now supplemented by owned hospital operations.

The Numbers: Even Healthcare Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Revenue claims conflict: Inc42 reported the company claimed $9M revenue in FY24, while another report cited a company claim of $28M about 1.5 years after commercial launch; reports differ.

Market Opportunity for Even Healthcare

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Even targets managed healthcare for urban Indian individuals and families, starting in Bengaluru.

Technology and Product at Even Healthcare

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Core capability: Public detail on Even Healthcare’s technology stack is limited beyond company-stated descriptions.
• Assessment lens: clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

Team and Culture at Even Healthcare

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Leadership: Mayank Banerjee, Matilde Giglio, Alessandro Ialongo are named as founders.
• Further detail on the wider team is limited in public sources.

Even Healthcare Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

• Direct competitors of Even Healthcare vary by product line; a verified rival comparison was not available from public sources.
• What to compare: Product readiness, pricing, customer base, funding runway and regulatory standing.

Risks and Challenges for Even Healthcare

• Revenue and profitability figures are inconsistent across reports.
• The model is concentrated in Bengaluru, and owned hospitals add capital intensity.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.
• Data privacy risk: health records are sensitive, and breaches or misuse can bring legal and reputational harm.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Even Healthcare Growth Outlook: What to Watch

• The company said the new capital would go toward expanding its Bengaluru hospital network and scaling its managed-care model (company-stated).
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Even Healthcare can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Even Healthcare Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Even Healthcare

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Even Healthcare.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Even Healthcare

Studying a company in the Managed care and hospitals space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Even Healthcare.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Even Healthcare as a Startup

• Customer clarity: Can Even Healthcare name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Even Healthcare is part of India’s growing Managed care and hospitals ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Even Healthcare FAQs: Frequently Asked Questions

What is Even Healthcare?

Even Healthcare is a managed-care healthtech startup based in Bengaluru, India, that provides membership-based consultations, diagnostics and cashless hospitalisation for individuals and families. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Even Healthcare?

Even Healthcare was founded by Mayank Banerjee, Matilde Giglio, Alessandro Ialongo, and the company reports a founding year of 2020.

How much funding has Even Healthcare raised?

About $70M (reported). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Even Healthcare make money?

Even Healthcare earns revenue from its Managed care and hospitals products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Even Healthcare?

Competitors of Even Healthcare depend on the specific product line. A verified comparison was not available, so see the evaluation checklist above.

What are the main risks for Even Healthcare?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Blurgs AI — Blurgs AI raises a reported $2.2M for maritime and defence AI | Pristyn Care — Pristyn Care: unicorn surgery startup with INR 381 Cr FY24 loss. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.